Search peptides, terms, sources/
Research source · 2025

Tirzepatide on obstructive sleep apnea-related cardiometabolic risk: secondary outcomes of the SURMOUNT-OSA randomized trial

About this source

Kind
Research
Design
Human clinical trial, RCT
Population
Adults with obesity and moderate-to-severe obstructive sleep apnoea
Primary or secondary
primary
Peer review
peer reviewed
Retraction status
None known
Date checked
14 August 2026

Limitations

Sponsor-funded; OSA-specific population.

Cited in

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.